To include your compound in the COVID-19 Resource Center, submit it here.

Emend regulatory update

Japan approved a regulatory application from Ono for IV Proemend fosaprepitant meglumine to

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE